CDC/IDSA COVID-19 Clinician Call: New Monoclonal Antibody EUA, New Data on Treatment Dispensing and More Vaccine Q&A

These one-hour webinars, held Saturdays at 3 p.m. ET, focus on timely issues of relevance to clinicians and feature case presentations by experts in the field, synthesis of new data, and an opportunity to engage with colleagues. Register for next week here.

Moderator:

Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA

Topics and Featured Experts:

Assessment of Outpatient Dispensing of Products Proposed for Treatment or Prevention of COVID-19 by U.S. Retail Pharmacies During the Pandemic

• CDR Jennifer N. Lind, PharmD, MPH
  Lead, Adverse Event Monitoring Unit
  CDC COVID-19 Health Systems and Worker Safety Task Force
• CAPT Daniel Budnitz, MD, MPH
  Director, Medication Safety Program
  Division of Healthcare Quality Promotion, CD

New Monoclonal Antibody EUA

• Wendy Carter, DO
  Lead Medical Officer of the Division of Antivirals
  US Food and Drug Administration
• Patrizia Cavazzoni, MD
  Acting Director of the Center for Drug Evaluation and Research
  US Food and Drug Administration
• Debra Birnkrant, MD
  Director of the Division of Antivirals
  US Food and Drug Administration
• Natalie Pica, MD, PhD
  Medical Officer of the Division of Antivirals
  US Food and Drug Administration
• John Farley, MD, MPH
  Director of the Office of Infectious Diseases
  US Food and Drug Administration
• Adam Sherwat, MD
  Deputy Director of the Office of Infectious Diseases
  US Food and Drug Administration

More COVID-19 Vaccine Q&A

• Sara Oliver, MD
  LCDR, U.S. Public Health Service
  Co-Lead, COVID-19 Work Group of the Advisory Committee on Immunization Practices
  Centers for Disease Control and Prevention